A Phase 2, Double-blind, Randomized, Placebo-controlled, Multicenter Trial to Assess the Efficacy, Safety, and Tolerability of AGMB-447 in Participants with Idiopathic Pulmonary Fibrosis (INSPIRIA)
Principal Investigator
Dr Peter Saunders
Contact us
Email: emcrf@ouh.nhs.uk
IRAS number
1014396